With 79857.0 shares changed hands, the volume of the stock remained lighter than its average volume of 0.31 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $6.195 whereas the lowest price it dropped to was $6.055. The 52-week range on MGTX shows that it touched its highest point at $7.60 and its lowest point at $3.85 during that stretch. It currently has a 1-year price target of $25.33. Beta for the stock currently stands at 1.26.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MGTX was down-trending over the past week, with a drop of -3.59%, but this was up by 4.05% over a month. Three-month performance surged to 53.48% while six-month performance rose 46.56%. The stock lost -12.73% in the past year, while it has lost -12.11% so far this year. A look at the trailing 12-month EPS for MGTX yields -1.31 with Next year EPS estimates of 0.70. For the next quarter, that number is -0.53. This implies an EPS growth rate of -22.26% for this year and 138.54% for next year.
Float and Shares Shorts:
At present, 77.70 million MGTX shares are outstanding with a float of 52.79 million shares on hand for trading. On 2024-10-31, short shares totaled 1.66 million, which was 215.0 higher than short shares on 1727654400. In addition to Dr. Alexandria Forbes Ph.D. as the firm’s CEO, President & Director, Mr. Richard Brian Giroux B.A. serves as its COO & CFO.
Institutional Ownership:
Through their ownership of 0.55127 of MGTX’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, MGTX reported revenue of $10910000.0 and operating income of -$40041000.0. The EBITDA in the recently reported quarter was -$35592000.0 and diluted EPS was -$0.55.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With MGTX analysts setting a high price target of 36.0 and a low target of 11.0, the average target price over the next 12 months is 21.0. Based on these targets, MGTX could surge 456.41% to reach the target high and rise by 70.02% to reach the target low. Reaching the average price target will result in a growth of 224.57% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.66889 being high and -$2.7325 being low. For MGTX, this leads to a yearly average estimate of -$1.82167.
